AYURCANN REPORTS RECORD SALES GROWTH IN Q3 2025 OF $14,179,974 AND PROVIDES CORPORATE UPDATE

AYURCANN REPORTS RECORD SALES GROWTH IN Q3 2025 OF $14,179,974 AND PROVIDES CORPORATE UPDATE

Toronto, Ontario, May 16, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”) is excited to announce record-breaking financial results for the three months ended March 31, 2025, the highlights of which are included…

Ayurcann loss in Q3 2025 with $6.5 million in excise

Ayurcann Holdings Corp. reported $7.6 million in net revenue and $2.9 million in gross profit in the three months ended March 31, 2025 (Q3 2025)... The post Ayurcann loss in Q3 2025 with $6.5 million in excise appeared first on StratCann.